A feasibility study of adjuvant therapy with capecitabine plus oxaliplatin (XELOX) for the patient with advanced colorectal cancer

ABSTRACT: Interventions: Adjuvant chemotherapy with capecitabine plus oxaliplatin Primary outcome(s): Patients ratio with completion of adjuvant XELOX therapy Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2618630 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR